Medication management

Apr 1, 2020
The AHA, American Medical Association, American Society of Anesthesiologists, American Society of Health-System Pharmacists, and Association for Clinical Oncology are urging the Drug Enforcement Agency to allow drug manufacturers and 503B outsourcing facilities to receive increased annual…
Jan 14, 2020
Multidisciplinary teams at the University of Tennessee Medical Center used lean methodology to create evidence-based care plans throughout any episode of care, including the ED, outpatient, inpatient, post-acute and home care.
Nov 6, 2019
The Food and Drug Administration yesterday approved the first test to use next generation sequencing technology to detect HIV drug-resistance mutations in patients taking or about to start antiviral therapy.
Oct 29, 2019
The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists and Institute for Safe Medication Practices today voiced strong support for the Mitigating Emergency Drug Shortages Act.
Oct 25, 2019
The Food and Drug Administration today alerted the public to growing concern about the potential for medical device shortages as facilities that sterilize devices using ethylene oxide close.
Oct 18, 2019
The House Energy and Commerce Committee last night approved a revised version of the Lower Prescription Drug Costs Now Act.
Oct 17, 2019
The Food and Drug Administration approved a record high 1,171 generic drugs in fiscal year 2019, the agency said today.
Oct 14, 2019
The Food and Drug Administration Oct. 11 approved a new tablet for the acute treatment of migraine headache pain.
Oct 11, 2019
The AHA today urged the Drug Enforcement Administration to explicitly consider drug shortages when setting and adjusting aggregate production quotas, citing concern that the agency’s proposal to reduce 2020 production quotas for five opioid controlled substances would exacerbate shortages of…
Sep 13, 2019
The Drug Enforcement Administration this week proposed reducing aggregate production quotas for five opioid controlled substances in 2020.